Additionally, 6 of the 10 PLMS cases exhibited a myostatin-negative/desmin-positive (diffuse or focal) phenotype, while 7 of the 17 high-grade sarcomas displayed a myostatin-positive (diffuse)/desmin-negative (or very focally positive) phenotype. Here, MSTN is linked to sarcoma.